Creation of Inceptua Clinical Trial Services Marks New Era for the Company

PR73179

LUXEMBOURG, Apr. 24, 2018 /PRNewswire=KYODO JBN/--

    Creation of Inceptua Clinical Trial Services Marks New Era for the Company

    Inceptua Group (previously Multipharma) today announces that its Clinical

Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services.

Going forward, all of the group's three business units including Clinical Trial

Services, Medicines Access and Commercial Products will be marketed under the

same corporate brand name, Inceptua.

    Since the founding in 1997, Inceptua Group - headquartered in Luxembourg -

has grown to become one of the leading global players in the clinical trial

services market, offering reliable sourcing and logistics expertise for

comparator drugs, clinical trial supplies, and clinical manufacturing services.

    "The name change marks the shift from Multipharma to Inceptua and a new era

for the company. We have a strong heritage sourcing medicine supplies for

clinical trials, and we will continue to strategically develop our offering in

this niche and operate as recognized experts in this area," says Alan

Raffensperger, Chief Executive Officer, Inceptua Group.

    "At the same time the change reflects that Inceptua as a group is further

developing our position as a strategic partner for pharma and biotech

companies, advising our clients on strategies and supporting them with

solutions and services across the entire value chain - clinical trials,

medicines access and commercialization of products. As of today, our new

trademark Inceptua allows us to market our combined offer to clients under the

same brand name, reflecting our strategy to be a trusted partner covering the

value chain from trial to commercialization."

    As of 2018, the company is operating from offices in Luxembourg, Germany,

Switzerland, Japan, the US, the UK, Sweden and China. Inceptua's multinational

team has a global network as well as people on the ground with local knowledge

and expertise. This extensive network of global connections means that while

the majority of purchasing is direct from manufacturers, the group also has

access to qualified distributors to meet customer needs, as well as critical

understanding of local and regional regulatory and compliance requirements.

    Looking ahead, Inceptua Group has a clear ambition to grow even further and

to help solve complex, medical challenges globally:

    "Our aim is to further realize the potential of our position as a trusted

partner for our clients, by understanding their needs and delivering value in a

long-term strategic partnership, both within clinical trial services as well as

in our other business areas, medicines access, and commercial products and

services. We offer a personalized approach and aim to provide our customers and

clients with solutions that positively impact patients' lives worldwide," says

Kay-Christian Karstadt, Chief Operating Officer.

    "We have seen a rapid, increasing and significant development of growth in

the need for clinical trial services to meet today's healthcare burden in areas

of high unmet medical need. It is our strategy with Inceptua Clinical Trial

Services to navigate the complex and highly dynamic environment, providing a

vital advisory role for customers and supporting them throughout the process."

    About Inceptua Clinical Trial Services

    Inceptua Clinical Trial Services offers a range of solutions, including

strategic planning, clinical trial supply sourcing, clinical manufacturing, and

end-to-end depot and distribution management to ensure the precise requirements

of your trial are met.

    The team has a thorough understanding of customers' requirements during the

procurement process, whether they require commercial drugs for comparator

trials or innovator products for biosimilar development.

    Inceptua Clinical Trial Services is a business unit of Inceptua, a

specialist multinational company headquartered in Luxembourg that has been

providing unlicensed medicines for named patient programs since 1997, and

medicine supplies for clinical trials since 2004. For more information, please

visit our website at http://www.inceptua.com.

    About Inceptua

    The Inceptua Group is a global, dynamic and future-oriented service

provider and partner for the pharmaceutical and biotech industry, providing

critical treatments to patients in need. Inceptua has global operations within

clinical trial supply chain and manufacturing, medicine access and unlicensed

medicines, as well as commercial products and services.

Source: Inceptua